140 related articles for article (PubMed ID: 36630734)
1. PP2Cα aggravates neuronal insulin resistance leading to AD-like phenotype in vitro.
Yadav Y; Dey CS
Biochem Biophys Res Commun; 2023 Feb; 644():49-54. PubMed ID: 36630734
[TBL] [Abstract][Full Text] [Related]
2. Protein phosphatase-2C alpha as a positive regulator of insulin sensitivity through direct activation of phosphatidylinositol 3-kinase in 3T3-L1 adipocytes.
Yoshizaki T; Maegawa H; Egawa K; Ugi S; Nishio Y; Imamura T; Kobayashi T; Tamura S; Olefsky JM; Kashiwagi A
J Biol Chem; 2004 May; 279(21):22715-26. PubMed ID: 15016818
[TBL] [Abstract][Full Text] [Related]
3. PP2Cα positively regulates neuronal insulin signalling and aggravates neuronal insulin resistance.
Yadav Y; Dey CS
FEBS J; 2022 Dec; 289(23):7561-7581. PubMed ID: 35810470
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
[TBL] [Abstract][Full Text] [Related]
5. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
[TBL] [Abstract][Full Text] [Related]
6. PP1γ regulates neuronal insulin signaling and aggravates insulin resistance leading to AD-like phenotypes.
Yadav Y; Sharma M; Dey CS
Cell Commun Signal; 2023 Apr; 21(1):82. PubMed ID: 37085815
[TBL] [Abstract][Full Text] [Related]
7. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
[TBL] [Abstract][Full Text] [Related]
8. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
Gupta A; Bisht B; Dey CS
Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
[TBL] [Abstract][Full Text] [Related]
9. PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance.
Gupta A; Dey CS
Mol Biol Cell; 2012 Oct; 23(19):3882-98. PubMed ID: 22875989
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
[TBL] [Abstract][Full Text] [Related]
11. Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer's Disease?
Hegde V; Dhurandhar NV; Reddy PH
J Alzheimers Dis; 2019; 72(s1):S71-S79. PubMed ID: 31744006
[TBL] [Abstract][Full Text] [Related]
12. AMPK: A bridge between diabetes mellitus and Alzheimer's disease.
Chen M; Huang N; Liu J; Huang J; Shi J; Jin F
Behav Brain Res; 2021 Feb; 400():113043. PubMed ID: 33307136
[TBL] [Abstract][Full Text] [Related]
13. Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation.
Kim B; Figueroa-Romero C; Pacut C; Backus C; Feldman EL
J Biol Chem; 2015 Jul; 290(31):19146-57. PubMed ID: 26100639
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity.
Jantrapirom S; Nimlamool W; Chattipakorn N; Chattipakorn S; Temviriyanukul P; Inthachat W; Govitrapong P; Potikanond S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138327
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer's disease.
Ali T; Rehman SU; Khan A; Badshah H; Abid NB; Kim MW; Jo MH; Chung SS; Lee HG; Rutten BPF; Kim MO
Mol Neurodegener; 2021 Apr; 16(1):23. PubMed ID: 33849621
[TBL] [Abstract][Full Text] [Related]
16. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
Zemva J; Schubert M
CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):322-37. PubMed ID: 24059318
[TBL] [Abstract][Full Text] [Related]
17. AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice.
Khandelwal M; Manglani K; Upadhyay P; Azad M; Gupta S
Neurobiol Dis; 2022 Nov; 174():105876. PubMed ID: 36162737
[TBL] [Abstract][Full Text] [Related]
18. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
20. DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells.
Kornelius E; Lin CL; Chang HH; Li HH; Huang WN; Yang YS; Lu YL; Peng CH; Huang CN
CNS Neurosci Ther; 2015 Jul; 21(7):549-57. PubMed ID: 26010513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
